Cargando…

Withdrawing biologics in non-systemic JIA: what matters to pediatric rheumatologists?

OBJECTIVE: Approximately one third of children with JIA receive biologic therapy, but evidence on biologic therapy withdrawal is lacking. This study aims to increase our understanding of whether and when pediatric rheumatologists postpone a decision to withdraw biologic therapy in children with clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Til, Janine A., Kip, Michelle M. A., Schatorjé, Ellen J. H., Currie, Gillian, Twilt, Marinka, Benseler, Susanne M., Swart, Joost F., Vastert, Sebastiaan J., Wulffraat, Nico, Yeung, Rae S. M., Groothuis-Oudshoorn, C. G. M. (Karin), Warta, Sanne, Marshall, Deborah A., IJzerman, Maarten J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337208/ https://www.ncbi.nlm.nih.gov/pubmed/37434157 http://dx.doi.org/10.1186/s12969-023-00845-4

Ejemplares similares

Seeking the state of the art in standardized measurement of health care resource use and costs in juvenile idiopathic arthritis: a scoping review
por: Kip, Michelle M. A., et al.
Publicado: (2019)

Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study
por: Grazziotin, Luiza R., et al.
Publicado: (2022)

Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis
por: Kip, Michelle M A, et al.
Publicado: (2022)

Genomic Health Literacy Interventions in Pediatrics: Scoping Review
por: Gupta, Aarushi, et al.
Publicado: (2021)

Costs of Hospital‐Associated Care for Patients With Juvenile Idiopathic Arthritis in the Dutch Health Care System
por: Kip, Michelle M. A., et al.
Publicado: (2022)

Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis
por: Grazziotin, Luiza R., et al.
Publicado: (2022)

Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort Study
por: Grazziotin, Luiza R., et al.
Publicado: (2021)

IL-1 receptor antagonist restores IL-18 NK cell axis in systemic JIA
por: Vastert, Sebastiaan J, et al.
Publicado: (2012)

Adverse events of methotrexate treatment in JIA
por: in ‘t Veld, J, et al.
Publicado: (2011)

Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis
por: Barber, Claire E. H., et al.
Publicado: (2020)

Evaluation of an nhs juvenile idiopathic arthritis (JIA) treatment pathway compared to published international recommendations
por: Green, Katherone L, et al.
Publicado: (2014)

Public stated preferences and predicted uptake for genome-based colorectal cancer screening
por: Groothuis-Oudshoorn, Catharina GM, et al.
Publicado: (2014)

Patient and Public Preferences for Treatment Attributes in Parkinson’s Disease
por: Weernink, Marieke G. M., et al.
Publicado: (2017)

Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care
por: Barber, Claire E.H., et al.
Publicado: (2019)

A Review and Classification of Approaches for Dealing with Uncertainty in Multi-Criteria Decision Analysis for Healthcare Decisions
por: Broekhuizen, Henk, et al.
Publicado: (2015)

Mesenchymal stem cells and JIA
por: Swart, JF, et al.
Publicado: (2011)

Contradictory and weak evidence on the effectiveness of anti-emetics for MTX-intolerance in JIA-patients
por: Schoemaker, Casper G., et al.
Publicado: (2018)

Recombinant IL1-RA in the early phase of systemic onset JIA: before the onset of arthritis
por: Vastert, SJ, et al.
Publicado: (2011)

The growing spectrum of antibody-associated inflammatory brain diseases in children
por: Bigi, Sandra, et al.
Publicado: (2015)

Strategies for treatment of childhood primary angiitis of the central nervous system
por: Beelen, Jocelyne, et al.
Publicado: (2019)

PReS-FINAL-2139: Tapering and withdrawal of tocilizumab in patients with systemic JIA in inactive disease: results from an alternative dosing regimen in the tender study
por: De Benedetti, F, et al.
Publicado: (2013)

Akinra restores the defective IL-18 NK cell axis in steroid naïve systemic onset JIA patients
por: de Jager, W, et al.
Publicado: (2011)

Comparison of CNS vasculitis in children and adults; is this the same disease entity
por: Twilt, Marinka, et al.
Publicado: (2012)

Comparison of CNS vasculitis in children and adults; is this the same disease entity
por: Twilt, Marinka, et al.
Publicado: (2011)

Patients’ Priorities for Oral Anticoagulation Therapy in Non-valvular Atrial Fibrillation: a Multi-criteria Decision Analysis
por: Weernink, Marieke G. M., et al.
Publicado: (2018)

Weighing Clinical Evidence Using Patient Preferences: An Application of Probabilistic Multi-Criteria Decision Analysis
por: Broekhuizen, Henk, et al.
Publicado: (2016)

Dynamic knee joint function in children with juvenile idiopathic arthritis (JIA)
por: Hansmann, Sandra, et al.
Publicado: (2015)

Involving Patients in Weighting Benefits and Harms of Treatment in Parkinson's Disease
por: Weernink, Marieke G. M., et al.
Publicado: (2016)

Puberty and disease activity in JIA
por: Van Pelt, Philomine, et al.
Publicado: (2014)

Tapering of biological treatment in autoinflammatory diseases: a scoping review
por: Welzel, Tatjana, et al.
Publicado: (2022)

PReS-FINAL-2362: The spectrum of childhood inflammatory brain diseases; an increasingly recognised field
por: Twilt, M, et al.
Publicado: (2013)

Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors
por: Gieling, Job, et al.
Publicado: (2022)

Estimating the value of medical treatments to patients using probabilistic multi criteria decision analysis
por: Broekhuizen, Henk, et al.
Publicado: (2015)

Distinguishing features in the presentations of childhood inflammatory brain diseases at a tertiary-care centre
por: Cellucci, Tania, et al.
Publicado: (2012)

Use of internet in adolescents and young adults with JIA
por: Van Pelt, Philomine, et al.
Publicado: (2014)

Prevention of disease flares by risk-adapted stratification of therapy withdrawal in juvenile idiopathic arthritis: results from the PREVENT-JIA trial
por: Gerss, Joachim, et al.
Publicado: (2022)

Women’s preferences, willingness-to-pay, and predicted uptake for single-nucleotide polymorphism gene testing to guide personalized breast cancer screening strategies: a discrete choice experiment
por: Wong, Xin Yi, et al.
Publicado: (2018)

IL-18 production upon s100 stimulation is reduced in active sJIA patients compared to sJIA patients in remission and healthy controls
por: Haar, Nienke Ter, et al.
Publicado: (2014)

Assessment of disease activity by patients with juvenile idiopathic arthritis and the parents compared to the assessment by pediatric rheumatologists
por: Armbrust, Wineke, et al.
Publicado: (2013)

Synovial Tissue Biopsy Collection by Rheumatologists: Ready for Clinical Implementation?
por: Smits, Marijn, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_78afno86osut4jsb5bg8uob449